Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China flag China · Delayed Price · Currency is CNY
14.86
+0.01 (0.07%)
Feb 4, 2026, 10:25 AM CST

SHE:002907 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
302.97456.55437.56503.53429.97481.41
Short-Term Investments
-30.3550---
Trading Asset Securities
290.43120.61--80.6150.07
Cash & Short-Term Investments
593.4607.51487.56503.53510.58531.47
Cash Growth
25.75%24.60%-3.17%-1.38%-3.93%10.71%
Accounts Receivable
282.9272.7245.46315.03238.5225.99
Other Receivables
4.513.064.249.64.334.29
Receivables
287.41275.76249.71324.63242.83230.27
Inventory
124.09140.13151.68114.76127.44118.57
Prepaid Expenses
-----0.04
Other Current Assets
84.127.955.6914.0313.258.66
Total Current Assets
1,0891,031894.64956.95894.1889.01
Property, Plant & Equipment
497.43537.74593.41621.94654.21673.61
Long-Term Investments
76.9293.6598.3984.4857.0536.92
Other Intangible Assets
213.31125.89107.1475.2676.7953.48
Long-Term Deferred Tax Assets
13.5317.2615.6918.6616.9618.59
Long-Term Deferred Charges
37.136.9760.9644.0124.8922.41
Other Long-Term Assets
70.3874.781.2365.3747.4827.39
Total Assets
1,9981,9181,8511,8671,7711,721
Accounts Payable
65.6664.3655.2348.0476.192.05
Accrued Expenses
8.632.329.4440.2926.9421.68
Short-Term Debt
-----12.01
Current Portion of Leases
37.670.090.140.110.13-
Current Income Taxes Payable
10.224.620.761.970.187.8
Current Unearned Revenue
8.559.745.696.734.3530.9
Other Current Liabilities
102.77100.9397.41114.1899.2791.36
Total Current Liabilities
233.47212.03188.68211.32206.97255.8
Long-Term Debt
----250.92235.35
Long-Term Leases
1.170.040.140.060.08-
Long-Term Unearned Revenue
39.9942.9943.0343.5946.3346.98
Long-Term Deferred Tax Liabilities
13.042.481.681.31.271.45
Total Liabilities
287.66257.55233.53256.28505.56539.59
Common Stock
417.6417.6417.6417.6401.69401.7
Additional Paid-In Capital
451.17459.33458.73454.72129.12130.79
Retained Earnings
819.85782.89741.66738.19659.79579.26
Treasury Stock
-----6.55-11.9
Comprehensive Income & Other
0.130.18-0.07-0.1181.8781.97
Total Common Equity
1,6891,6601,6181,6101,2661,182
Minority Interest
21.29-----
Shareholders' Equity
1,7101,6601,6181,6101,2661,182
Total Liabilities & Equity
1,9981,9181,8511,8671,7711,721
Total Debt
38.840.130.280.17251.12247.36
Net Cash (Debt)
554.56607.39487.28503.36259.45284.11
Net Cash Growth
17.56%24.65%-3.19%94.01%-8.68%9.38%
Net Cash Per Share
1.331.451.171.250.650.71
Filing Date Shares Outstanding
417.6417.6417.6417.6401.71401.7
Total Common Shares Outstanding
417.6417.6417.6417.6401.69401.7
Working Capital
855.56819.31705.96745.63687.13633.21
Book Value Per Share
4.043.983.873.863.152.94
Tangible Book Value
1,4751,5341,5111,5351,1891,128
Tangible Book Value Per Share
3.533.673.623.682.962.81
Buildings
-310.3310.25297.72292.53290.78
Machinery
-598.97582.48566.85536.22427
Construction In Progress
-10.1925.7817.5223.5595.9
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.